Dr. Pradip Sen

Dr. Pradip Sen

Chief Scientist

Previous research efforts of our laboratory were focused on two important aspects related to the diseases kala-azar and cancer. The first entailed characterization of host immune responses against drug-resistant or susceptible Leishmania parasites, the causative agents of kala-azar. The second research aspect in tumor immunobiology led us to identify c-Src and Bruton’s tyrosine kinase as potential targets for anti-cancer therapy. Efforts are ongoing to identify new receptor(s) mediating Leishmania infection. In addition, our translational activities include development of biosimilar therapeutic monoclonal antibodies for the treatment of autoimmune diseases and cancer. In brief, our ongoing work encompasses both fundamental and applied research on cancer, infectious and autoimmune diseases.

Last Modified Date:- 17-02-2025

Back to Previous Page